Upstream Bio (NASDAQ:UPB) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Upstream Bio (NASDAQ:UPB) from a sell rating to a hold rating in a research report report published on Friday.

Upstream Bio Price Performance

UPB opened at $11.27 on Friday. Upstream Bio has a 1 year low of $5.14 and a 1 year high of $29.46. The stock has a fifty day moving average price of $8.60 and a 200 day moving average price of $11.39.

Upstream Bio (NASDAQ:UPB) last posted its earnings results on Tuesday, May 6th. The company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.49) by ($0.02). The business had revenue of $0.57 million during the quarter, compared to the consensus estimate of $0.71 million. Research analysts expect that Upstream Bio will post -4.3 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Upstream Bio

A number of institutional investors have recently made changes to their positions in UPB. BNP Paribas Financial Markets acquired a new stake in Upstream Bio during the fourth quarter worth about $25,000. US Bancorp DE acquired a new stake in Upstream Bio during the fourth quarter valued at approximately $27,000. Legal & General Group Plc acquired a new position in shares of Upstream Bio in the 4th quarter worth approximately $28,000. New York State Common Retirement Fund acquired a new position in shares of Upstream Bio in the 1st quarter worth approximately $29,000. Finally, Summit Investment Advisors Inc. acquired a new position in shares of Upstream Bio in the 4th quarter worth approximately $30,000.

About Upstream Bio

Upstream Bio, Inc, a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease.